BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

Her scheme of enlisting foreign governments to stop U.S. mergers suffered a blow Tuesday when Europe’s high court ruled that regulators in Brussels exceeded their authority by blocking Illumina ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

San Diego gene-sequencing pioneer Illumina on Tuesday won its court fight against the European Union’s investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...

Why has Illumina stock lost one third of its value in the 12 months from August 1, 2023 to August 1, 2024? Why are some scientists, such as those I have heard at genomics conferences, discussing ...

With the recent wrapping up of the World Cancer Congress 2024 in Geneva, Switzerland, and the European Society for Medical ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Europe’s top court dealt a blow to Brussels regulators on Tuesday after it agreed with US biotech ...

On September 3, 2024, the EU’s highest court, the European Court of Justice (ECJ), ruled that the European Commission (EC) had no jurisdiction to review Illumina’s acquisition of Grail ...

BENGALURU: Illumina, a global leader in DNA sequencing and array-based technologies, announced it will establish a Global CapabilityCenter in Bengaluru to expand its technology workforce in ...